Table 3.
Maternal adverse effects of the two treatments.
| Secondary | Nifedipine+placebo | Nifedipine+VD | |
|---|---|---|---|
| endpoints | (n = 304) | (n = 298) | |
| No adverse effect | 262 (86.2%) | 259 (86.9%) | NS |
| Nausea | 13 (4.3%) | 11 (3.7%) | NS |
| Vomiting | 7 (2.3%) | 8 (2.7%) | NS |
| Maternal tachycardia | 7 (2.3%) | 5 (1.7%) | NS |
| Mild headache | 5 (1.6%) | 5 (1.7%) | NS |
| Dizziness | 4 (1.3%) | 5 (1.7%) | NS |
| Chest pain | 2 (0.7%) | 3 (1.0%) | NS |
| Hypotension | 2 (0.7%) | 1 (0.3%) | NS |
| Shortness of breath | 2 (0.7%) | 1 (0.3%) | NS |
Percentages do not add up to 100 due to rounding. NS, not significant.